Evie H Carchman

7PUBLICATIONS
44CO-AUTHORS
ChemotherapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.

|Feb 11, 2026
Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer.

Dustin A Deming, Sean G Kraus, Joshua Brand

|Sep 28, 2024
Topical Protease Inhibitor Increases Tumor-Free and Overall Survival in CD4-Depleted Mouse Model of Anal Cancer.

Evan Yao, Laura Gunder, Tyra Moyer

|Sep 14, 2024
Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil.

Alyssa K DeZeeuw, Michael F Bassetti, Evie H Carchman

|Dec 23, 2023
Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.

Taja Lozar, Wei Wang, Niki Gavrielatou

|Apr 28, 2023
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.

Laura C Gunder, Hillary R Johnson, Evan Yao

Pageof 2

Frequent Collaborators

2 joint publications

Cristina Sanger

2 joint publications

Cheri A Pasch

2 joint publications

Kristina Matkowskyj

2 joint publications

Hillary R Johnson